Mutations in the wolfram syndrome type 1 gene (WFS1) define a clinical entity of dominant low-frequency sensorineural hearing loss. Commentary

Conference proceeding

Marci M Lesperance, James W Hall, Theresa B Agustin, Suzanne M Leal, Richard J. H Smith and Patrick L. M Huygen

Archives of otolaryngology, head & neck surgery, Vol.129(4), pp.411-406

2003

Additional Links

Biological and medical sciences

Ear, auditive nerve, cochleovestibular tract, facial nerve: diseases, semeiology

Medical sciences

Non tumoral diseases

Otorhinolaryngology. Stomatology

2 Record Views

Title: Mutations in the wolfram syndrome type 1 gene (WFS1) define a clinical entity of dominant low-frequency sensorineural hearing loss. Commentary
Creators: Marci M Lesperance - University of Michigan–Ann Arbor
James W Hall - Department of Communicative Disorders, College of Health Professions, University of Florida, Gainesville, United States
Theresa B Agustin - National Institute on Disability and Rehabilitation Research, Washington, DC, United States
Suzanne M Leal - Rockefeller University
Richard J. H Smith - University of Iowa
Patrick L. M Huygen - University of Michigan–Ann Arbor
Publication Details: Archives of otolaryngology, head & neck surgery, Vol.129(4), pp.411-406
Publisher: American Medical Association
Resource Type: Conference proceeding
Language: English
Academic Unit: Audiology - Distance
Identifiers: 991022019601704721